Liposyn infusion increases plasma prostaglandin concentrations.
To determine whether Liposyn infusion results in increased plasma prostaglandin (PG) concentrations, the following study was performed in 33 adult rabbits with chronically implanted arterial and venous catheters. Plasma PG concentrations were determined by radioimmunoassay for two vasodilators, PGE2 and PGI2 (as measured by its metabolite 6-keto-PGF1 alpha), and two vasoconstrictors, thromboxane (TX) A2 and PGF2 alpha, as measured by their metabolites TXB2 and PGF2 alpha-M, respectively. A 1-hour infusion of Liposyn at 4 ml per kg resulted in statistically significant increases in arterial and venous concentrations of PGE2 and 6-keto-PGF1 alpha (p less than 0.001) and of TXB2 (p less than 0.04). There were no significant changes in PGF2 alpha-M plasma concentrations. Liposyn infusion also resulted in a small but statistically significant increase in PaO2 of 4.7 +/- 1.5 torr (p less than 0.01). It is concluded that Liposyn infusion results in statistically significant increases in plasma concentrations of PGE2, 6-keto-PGF1 alpha, and TXB2.
Hunt
C E
CE
Pachman
L M
LM
Hageman
J R
JR
Cobb
M A
MA
Klemka
L
L
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D015237:Dinoprost; D015232:Dinoprostone; D004655:Emulsions; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology*; D054709:Lecithins; D011453:Prostaglandins / Q000097:blood*; D011458:Prostaglandins E / Q000097:blood; D011460:Prostaglandins F / Q000097:blood; D011817:Rabbits; D012450:Safflower Oil; D013024:Soybean Oil; D013929:Thromboxane B2 / Q000097:blood; D014280:Triglycerides / Q000032:analysis
D004655:Emulsions; D005217:Fat Emulsions, Intravenous; D054709:Lecithins; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D014280:Triglycerides; C031435:safflower oil, soybean oil, lecithin emulsion; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D013024:Soybean Oil; D012450:Safflower Oil; D015237:Dinoprost; D015232:Dinoprostone